Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2009 7
2010 1
2011 3
2012 2
2013 6
2014 1
2017 1
2018 1
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
Skrip L, Derra K, Kaboré M, Noori N, Gansané A, Valéa I, Tinto H, Brice BW, Gordon MV, Hagedorn B, Hien H, Althouse BM, Wenger EA, Ouédraogo AL. Skrip L, et al. Among authors: gansane a. Int J Infect Dis. 2020 Dec;101:194-200. doi: 10.1016/j.ijid.2020.09.1432. Epub 2020 Sep 26. Int J Infect Dis. 2020. PMID: 32987177 Free PMC article.
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.
Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB. Ouédraogo A, et al. Among authors: gansane a. PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013. PLoS One. 2013. PMID: 24244339 Free PMC article. Clinical Trial.
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud M, Benhamouda N, Nebié I, Faber B, Remarque E, Launay O; AMA1-DiCo Study Group. Sirima SB, et al. Among authors: gansane a. Vaccine. 2017 Oct 27;35(45):6218-6227. doi: 10.1016/j.vaccine.2017.09.027. Epub 2017 Sep 22. Vaccine. 2017. PMID: 28947345 Clinical Trial.
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns.
Yelemkoure ET, Yonli AT, Montesano C, Ouattara AK, Diarra B, Zohoncon TM, Nadembega CWM, Ouedraogo P, Sombié C, Soubeiga ST, Tao I, Gansane A, Amicosante M, Djigma F, Obiri-Yeboah D, Pietra V, Simpore J, Colizzi V. Yelemkoure ET, et al. Among authors: gansane a. J Public Health Afr. 2018 Dec 21;9(3):816. doi: 10.4081/jphia.2018.816. eCollection 2018 Dec 21. J Public Health Afr. 2018. PMID: 30687485 Free PMC article.
In vitro antiplasmodial activity of some medicinal plants of Burkina Faso.
Ouattara LP, Sanon S, Mahiou-Leddet V, Gansané A, Baghdikian B, Traoré A, Nébié I, Traoré AS, Azas N, Ollivier E, Sirima SB. Ouattara LP, et al. Among authors: gansane a. Parasitol Res. 2014 Jan;113(1):405-16. doi: 10.1007/s00436-013-3669-8. Epub 2013 Dec 8. Parasitol Res. 2014. PMID: 24318747
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono AB, Ouédraogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood B, Diallo DA. Konaté AT, et al. Among authors: gansane a. PLoS Med. 2011 Feb 1;8(2):e1000408. doi: 10.1371/journal.pmed.1000408. PLoS Med. 2011. PMID: 21304925 Free PMC article. Clinical Trial.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page